Literature DB >> 7979952

Effects of antimurine interleukin-6 on bacterial translocation during gut-derived sepsis.

R Gennari1, J W Alexander, T Pyles, S Hartmann, C K Ogle.   

Abstract

BACKGROUND: Recent studies have shown that interleukin-6 (IL-6) is involved in the systemic changes that are associated with infection and tissue injury and that there is a correlation between high levels of IL-6 and poor outcome during several pathologic conditions.
OBJECTIVE: The effects of antimurine IL-6 antibody on survival and host defense were studied in a clinically relevant model of infection.
METHODS: Balb/c mice were treated with 10 micrograms of antimurine interleukin-6, a nonspecific mouse IgG, or placebo 1 hour before they underwent bacterial challenge by gavage of 10(10) Escherichia coli and burn injury. Survival and the extent of translocation of E coli were determined as well as the correlation between the IL-6 levels and survival times.
RESULTS: Survival after burn and gavage was 90% in animals treated with antimurine interleukin-6 vs 50% in animals treated with nonspecific IgG and 30% in saline-treated controls. A significant correlation between the levels of IL-6 and survival time was observed. Less translocation and better killing of bacteria were observed in the tissues of animals treated with antimurine interleukin-6.
CONCLUSIONS: Interleukin-6 appears to play a major role in both the intensity of translocation of E coli from the intestine following burn injury and the host's ability to kill translocated organisms. Improved outcome was associated with a reduction of IL-6 levels by anti-IL-6 antibody.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979952     DOI: 10.1001/archsurg.1994.01420350089012

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  5 in total

1.  The detection of microbial DNA in the blood: a sensitive method for diagnosing bacteremia and/or bacterial translocation in surgical patients.

Authors:  T D Kane; J W Alexander; J A Johannigman
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

Review 2.  Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

Authors:  W L Biffl; E E Moore; F A Moore; V M Peterson
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

3.  Interleukin-6 changes tight junction permeability and intracellular phospholipid content in a human enterocyte cell culture model.

Authors:  Y Tazuke; R A Drongowski; D H Teitelbaum; A G Coran
Journal:  Pediatr Surg Int       Date:  2003-05-06       Impact factor: 1.827

4.  Survival and cell mediated immunity after burn injury in aged mice.

Authors:  Elizabeth J Kovacs; Kristy A Grabowski; Lisa A Duffner; Timothy P Plackett; Meredith S Gregory
Journal:  J Am Aging Assoc       Date:  2002-01

5.  Beneficial Effects of Anti-Interleukin-6 Antibodies on Impaired Gastrointestinal Motility, Inflammation and Increased Colonic Permeability in a Murine Model of Sepsis Are Most Pronounced When Administered in a Preventive Setup.

Authors:  Sara Nullens; Michael Staessens; Cédric Peleman; Philip Plaeke; Surbhi Malhotra-Kumar; Sven Francque; Joris G De Man; Benedicte Y De Winter
Journal:  PLoS One       Date:  2016-04-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.